Positive association of DRB1*04 and DRB1*15 alleles with Fya immunization in a Southern European population

Transfusion

Volumn 49, Issue 11, 2009, Pages 2412-2417

  Chiaroni, Jacques ^a   Picard, Chistophe ^b   Frassati, Coralie ^b   Basire, Agnes ^b   Buhler, Stephan ^b   Galicher, Vital ^b   Ferrera, Virginie ^b   Reviron, Denis ^b   Zappitelli, Jean Pierre ^b   Bailly, Pascal ^b  

^a AIX MARSEILLE UNIVERSITÉ   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN;

ALLOIMMUNIZATION; AMINO ACID SEQUENCE; ARTICLE; BLOOD GROUP DUFFY SYSTEM; BLOOD TRANSFUSION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENOTYPE; HLA SYSTEM; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREGNANCY;

ALLELES; DUFFY BLOOD-GROUP SYSTEM; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HLA-DR ANTIGENS; HUMANS; ISOANTIBODIES; MALE; POLYMERASE CHAIN REACTION;

EID: 70449127972     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02369.x     Document Type: Article

References (20)

1. Shirey RS, King KE. Alloimmunization to blood group antigens. In : Anderson KC, Ness PM, editors. Scientific basis of transfusion medicine. 2nd ed. Philadelphia (PA) : Saunders 2000. p. 330 400.
2. Ansart-Pirenne H, Zeliszewski D, Lee K, Martin-Blanc S, Rouger P, Noizat-Pirenne F. Identification of immunodominant alloreactive t-cell epitopes on the Jka red blood cell protein inducing either th1 or th2 cytokine expression. Blood 2004 104 : 3409.
3. Schonewille H, Brand A. Alloimmunization to red blood cell antigens after universal leucodepletion. A regional multicentre retrospective study. Br J Haematol 2005 129 : 151 6.
4. Schonewille H, van de Watering LM, Loomans DS, Brand A. Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity. Transfusion 2006 46 : 250 6.
5. Reviron D, Dettori I, Ferrera V, Legrand D, Touinssi M, Mercier P, de Micco P, Chiaroni J. HLA-DRB1 alleles and Jk(a) immunization. Transfusion 2005 45 : 956 9.
6. Chiaroni J, Dettori I, Ferrera V, Legrand D, Touinssi M, Mercier P, de Micco P, Reviron D. HLA-DRB1 polymorphism is associated with Kell immunisation. Br J Haematol 2006 132 : 374 8.
7. Noizat-Pirenne F, Tournamille C, Bierling P, Roudot-Thoraval F, Le Pennec PY, Rouger P, Ansart-Pirenne H. Relative immunogenicity of Fya and K antigens in a Caucasian population, based on HLA class II restriction analysis. Transfusion 2006 46 : 1328 33.
8. Lerut E, Van Damme B, Noizat-Pirenne F, Emonds MP, Rouger P, Vanrenterghem Y, Pirenne J, Anssart-Pirenne H. Duffy and Kidd blood group antigens: minor histocompatibility antigens involved in renal allograft rejection? Transfusion 2007 47 : 28 40.
9. Hughes LH, Rossi KQ, Krugh DW, O'Shaughnessy RW. Management of pregnancies complicated by anti-Fy(a) alloimmunization. Transfusion 2007 47 : 1858 61.
10. Watorek E, Boratynska M, Halon A, Klinger M. Anti-Fya antibodies as the cause of an unfortunate post-transplant course in renal transplant recipient. Ann Transpl 2008 13 : 48 52.
11. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992 39 : 225 35.
12. Bignon JD, Fernandez-Vina M. SSO protocol for the HLA-DNA typing technique. In : Charron D, Fauchet R, editors. Twelfth International Histocompatibility Workshop reference protocol addendum. Technical handbook. Paris : HLA et Médecine 1996. p. 445 52.
13. Haldane JB. The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 1956 20 : 309 11.
14. Reviron D, Tezenas du Montcel S, Foutrier C, Guis S, Benazet JF, Auquier P, Busson M, Roux H, Mercier P, Roudier J. HLA DRB1, DMA, and DMB gene polymorphisms in rheumatoid arthritis. Hum Immunol 1999 60 : 245 9.
15. Alizadeh M, Genin E, Babron MC, Birebent B, Cournu-Rebeix I, Yaouang J, Dréano S, Sawcer S, Compston A, Clanet M, Edan G, Fontaine B, Clerget-Darpoux F, Semana G French Multiple Sclerosis Genetics Group. Genetic analysis of multiple sclerosis in Europeans: French data. J Neuroimmunol 2003 143 : 74 8. (Pubitemid 37324288)
16. Oldenburg J, Picard JK, Schwaab R, Brackmann HH, Tuddenham EG, Simpson E. HLA genotype of patients with severe haemophilia A due to intron 22 inversion with and without inhibitors of factor VIII. Thromb Haemost 1997 77 : 238 42.
17. Hall AM, Cairns LS, Altmann DM, Barker RN, Urbaniak SJ. Immune responses and tolerance to the RhD blood group protein in HLA-transgenic mice. Blood 2005 105 : 2175 9.
18. Wucherpfennig KW, Yu B, Bhol K, Monos DS, Argyris E, Karr RW, Ahmed AR, Strominger JL. Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. Proc Natl Acad Sci U S A 1995 92 : 11935 9.
19. Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL, Wiley DC. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 1994 368 : 215 21.
20. Schonewille H, Haak HL, van Zijl AM. RBC antibody persistence. Transfusion 2000 40 : 1127 31.